(I-MED Pharma) Did you know that woman over the age of 50 have a higher risk of dry eye problems? According to the American Academy of Ophthalmology, dry eye disease (DED) affects over 3.2 million American women middle aged and over.[1]Hormonal changes associated with menopause make dry eye disease more prevalent among women in this […]
Montreal, February 3, 2022 (Globe Newswire) With the recent launch of its line of dry eye diagnostics, management, and treatment solutions into the United States, I-MED Pharma USA has partnered with DryEye Rescue of Boca Raton, Florida to distribute and market their unique and innovative dry eye product portfolio. DryEye Rescue will help raise awareness […]
January 24, 2022 I-MED Pharma continues to grow and expand! We are pleased to announce that our corporate office is moving to the new location indicated below, effective January 31, 2022. 7190 Frederick Banting Rd. St. Laurent, QC H4S 2A1 Our new headquarters will allow us to better serve our growing clientele, with a larger […]
(I-MED Pharma) It’s the end of the year, one of our busiest yet, and this holiday season we would like to take a moment to reflect on all the positive events that have happened over the last 12 months at I-MED Pharma. As always, we are continuously #advancingthescienceofdryeye, most recently through the publication of two […]
Montreal, December 15, 2021 (GLOBE NEWSWIRE) NTC Srl, R&D driven pharmaceutical company with headquarters in Italy, and I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, announced today that I-DEFENSE®, a long-lasting, lubricating ointment with lanolin and mineral oil indicated for the relief of dry eyes and lagophthalmos symptoms has been […]
MONTREAL, December 9, 2021 (GLOBE NEWSWIRE) I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, is proud to announce the expansion of their strategic partnership with ESW Vision in France to be their exclusive distributor in the United States. Through I-MED Pharma USA, two revolutionary dry eye devices will be available […]
(I-MED Pharma) With Benjamin Itzkow, O.D. “It is very important to ask the question about whether a patient has dry eye, because if you don’t ask the question, then you don’t get the answer, which is what happens most of the time.” – Dr. Itzkow Eye drops are a standard management option for many conditions […]
Montreal, November 9, 2021 (Globe Newswire) With the recent expansion into the United States, I-MED Pharma USA is proud to announce the appointment of Michelle Schnabel to the role of VP Business Development effective November 1st, 2021. Michelle brings a wealth of experience to this role given her many years in leadership positions within the […]
Montreal, November 8, 2021 (Globe Newswire) With the recent expansion into the United States, I-MED Pharma USA is proud to announce the appointment of Brent Jones to Chief Commercial Officer effective November 1st, 2021. Brent brings a wealth of experience to this role given his many years in leadership positions in both the Marketing and […]
(I-MED Pharma) Meibomian Gland Dysfunction (MGD) is a major factor in Dry Eye Disease (DED), with upwards of 86% of DED sufferers showing evidence of MGD.[1] This chronic condition of the meibomian glands occurs due to duct obstruction and/or when there is a lack in the quality or quantity of meibum – the lipid component […]
October 7, 2021 (Montreal, QC, Canada) Article published in September issue of MEDTECH OUTLOOK Magazine medicaltechoutlook.com Ocular surface disorders (OSDs) typically indicate damage to the surface layers of the eye, namely the cornea, conjunctiva, eyelids, and lacrimal glands, causing irritation, redness, and inflammation of the eye, among other symptoms. OSDs include conditions like Dry Eye […]
Montreal, QC, Canada Article published in Optical Prism October issue ANNE MARIE QUENNEVILLE – VP OF SALES & BRAND MANAGEMENT FEATURED IN OPTICAL PRISM MAGAZINE AS A VISIONARY WOMAN IN THE FIELD OF EYE CARE! Women rock-stars in optical BY SUZANNE SENDEL It is with great honour that I have been invited to do a […]
